0001071739-11-000034.txt : 20111216 0001071739-11-000034.hdr.sgml : 20111216 20111216071413 ACCESSION NUMBER: 0001071739-11-000034 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20111216 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20111216 DATE AS OF CHANGE: 20111216 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CENTENE CORP CENTRAL INDEX KEY: 0001071739 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 041406317 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31826 FILM NUMBER: 111264855 BUSINESS ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 BUSINESS PHONE: 3147254477 MAIL ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 8-K 1 form8k.htm FORM 8-K form8k.htm


 
UNITED STATES
 
 
SECURITIES AND EXCHANGE COMMISSION
 
 
Washington, D.C. 20549
 
 


 
FORM 8-K
 
 

 
 
Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
 
Date of report (Date of earliest event reported): December 16, 2011
 
 
CENTENE CORPORATION
 
 
(Exact name of registrant as specified in its charter)
 
 
Delaware
(State or other jurisdiction of incorporation)
 
001-31826
(Commission file number)
 
42-1406317
(IRS Employer Identification No.)
 
 
7700 Forsyth Boulevard, St. Louis, Missouri 63105
 
 
(Address of principal executive office and zip code)
 
 
Registrant’s telephone number, including area code: (314) 725-4477
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
o
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
o
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
o
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
o
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 


 
 
 
 
 
 
ITEM 7.01 REGULATION FD DISCLOSURE
 
 
On December 16, 2011, the Company issued a press release announcing its 2012 financial guidance and reaffirming its 2011 financial guidance. The full text of the press release is included as Exhibit 99.1 to this report. The information contained in the website cited in the press release is not a part of this report.
 
 
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
 
 
(d) Exhibits.
 
 
99.1 Press release of Centene Corporation issued December 16, 2011.
 
 
 

 
 
 
SIGNATURE
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
       
Date: December 16, 2011
CENTENE CORPORATION
 
By:
/s/ WILLIAM N. SCHEFFEL
   
William N. Scheffel
   
Executive Vice President, Chief Financial Officer and Treasurer
 
 
 

 
 
 
EXHIBIT INDEX
 
 
     
Exhibit
   
Number
 
Description
99.1
 
Press release of Centene Corporation issued December 16, 2011.
 

 

 
EX-99.1 2 exhibit991.htm PRESS RELEASE DATED DECEMBER 16, 2011 exhibit991.htm
Exhibit 99.1
GRAPHIC

N E W S  R E L E A S E
 
Contacts:       Media                                                 Investors
                        Deanne Lane                                     Edmund E. Kroll, Jr.
    (314) 725-4477                                   (212) 759-0382
 
FOR IMMEDIATE RELEASE

CENTENE CORPORATION ANNOUNCES 2012 FINANCIAL GUIDANCE
-- Premium & Service Revenues of $7.2 billion to $7.6 billion --
-- Earnings per diluted share of $2.60 to $2.80 --
 
ST. LOUIS (December 16, 2011)—Centene Corporation (NYSE: CNC) announced today its 2012 financial guidance.  The Health Benefits Ratio and the General and Administrative expense ratio below reflect the reclassification of certain General and Administrative expenses and Medical Costs to reflect the National Association of Insurance Commissioners (NAIC) definitions released earlier this year.
 
For its 2012 fiscal year, the Company expects:
 
·  
Premium and Service Revenues in the range of $7.2 billion to $7.6 billion.
 
·  
Earnings per diluted share of approximately $2.60 to $2.80.
 
·  
Consolidated Health Benefits Ratio of approximately 87.0% to 88.0%.
 
·  
Consolidated G&A expense ratio in the range of 9.5% to 10.0%.
 
·  
Effective tax rate, excluding non-controlling interest, of approximately 38.5% to 39.0% and diluted shares outstanding of approximately 53.4 million.
 
·  
Days in claims payable between 39 and 44.
 
The table below illustrates the reclassification of certain General and Administrative expenses and Medical Costs to reflect the new NAIC definitions.  The reclassifications will be made to historical periods for comparability and have no impact on net earnings. The Company’s 2011 and 2012 guidance is shown in the table below.
 
 
2011 Guidance
 
2012 Guidance
 
Health Benefits Ratio:
       
Historical
83.2% - 83.6%
 
84.9% - 85.9%
 
NAIC reclassification impact1
2.0%
 
2.1%
 
Revised
85.2% - 85.6%
 
87.0% - 88.0%
 
         
G&A expense ratio:
       
Historical
12.9% - 13.4%
 
11.5% - 12.0%
 
NAIC reclassification impact1
(1.9)%
 
(2.0)%
 
Revised
11.0% - 11.5%
 
9.5% - 10.0%
 
         
___________________________________________________
1 The percentage impact on the HBR and the G&A expense ratio differs as a result of utilizing different denominators in each formula (HBR is calculated as Medical Costs divided by Premium Revenue; the G&A expense ratio is calculated as G&A expense divided by Premium and Service Revenues).
 
Additionally, the Company reaffirms its 2011 guidance as follows:
 
 
2011 Guidance
 
2012 Guidance
 
Premium and Service Revenues (in millions)
$5,100 - $5,200
 
$7,200 - $7,600
 
         
Earnings per diluted share
$2.09 - $2.13
 
$2.60 - $2.80
 
         
Tax rate (excluding noncontrolling interest)
37.3% - 37.8%
 
38.5% - 39.0%
 
         
Diluted shares (in thousands)
52,500
 
53,400
 

Full year 2011 earnings will be reported on February 7, 2012, at 6:00 AM, with the conference call at 8:30 AM (Eastern Time).

Centene will host an investor meeting, including a question-and-answer session, to discuss the details of its guidance. The meeting will begin promptly today at 8:30 AM (Eastern Time) and end approximately at 11:00 AM (Eastern Time).  Michael F. Neidorff, Chairman and Chief Executive Officer, and William N. Scheffel, Executive Vice President, Chief Financial Officer and Treasurer, of Centene Corporation will host the meeting before an audience of investors at the New York Helmsley Hotel on East 42nd Street in New York City.

Investors and other interested parties who are unable to attend in person are invited to listen to the investor meeting via a live audio webcast on the Company's website at www.centene.com, under the Investors section. In addition, questions can be submitted via e-mail at: Questions@centene.com.

About Centene Corporation
Centene Corporation, a Fortune 500 company, is a leading multi-line healthcare enterprise that provides programs and related services to the rising number of under-insured and uninsured individuals. Many receive benefits provided under Medicaid, including the Children’s Health Insurance Program (CHIP), as well as Aged, Blind or Disabled (ABD), Foster Care, long-term care, other state-sponsored programs and Medicare (Special Needs Plans). Centene’s CeltiCare subsidiary offers states unique “exchange-based” and other cost-effective coverage solutions for low-income populations. The company operates local health plans and offers a range of health insurance solutions. It also contracts with other healthcare and commercial organizations to provide specialty services including behavioral health, life and health management, managed vision, telehealth services, and pharmacy benefits management. More information regarding Centene is available at www.centene.com.

The information provided in this press release contains forward-looking statements that relate to future events and future financial performance of Centene. Subsequent events and developments may cause the Company's estimates to change. The Company disclaims any obligation to update this forward-looking financial information in the future. Readers are cautioned that matters subject to forward-looking statements involve known and unknown risks and uncertainties, including economic, regulatory, competitive and other factors that may cause Centene's or its industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Actual results may differ from projections or estimates due to a variety of important factors, including Centene's ability to accurately predict and effectively manage health benefits and other operating expenses, competition, changes in healthcare practices, changes in federal or state laws or regulations, inflation, provider contract changes, new technologies, reduction in provider payments by governmental payors, major epidemics, disasters and numerous other factors affecting the delivery and cost of healthcare. The expiration, cancellation or suspension of Centene's Medicaid Managed Care contracts by state governments would also negatively affect Centene.

###


GRAPHIC 3 graphic.gif GRAPHIC begin 644 graphic.gif M1TE&.#EA]P`]`/<``````(````"``("`````@(``@`"`@+^_P,#RE!;C$T:S$Q=3`Z8C([S(]@"]`;3`_?CD\>SDYA#M%7#E# M9S5&=3E#@#I(:SM*@CE*C#M2ACQD-)A$)09D%/=$)1 MA4%65M MC&1JEF)JFV%OH6-VE6%SGV=UHVIG;VMGFVMK:VILE&IPG6YXJ&R+I7-S7EYJ[-O6W=[>WMSY^CG[.KL M].KO\^SJ\^[N\._Q]>_W__7R^/?O__CX^/K\_/[^_O_[\)^?GWU]??\```#_ M`/__````__\`_P#______RP`````]P`]```(_P#K"1Q(L*#!@P@3*ES(L*'# MAQ`C2IQ(L:+%@N^@O:)5JQ9'CK5@F7MWL:3)DRA3JEPY4=V9"2!BN(BQ`@0, M%RA6N"@!@M,VA,10O5+ERI6JH459#27*RBA3IZYHU7M'E*C1I:_F)73G]%73 MJU:/6E6JZFE95TW+>BTJUA4J:,=0L5V*%FK:HU_%JLHED-X\>GX#^U4(^._? MP%K['CY<&'!CQ(T3#WSG3C)+5#\>?`#AH06*#RXZLP#M0<0#&8E^%@RCH$*# M"!,65'@`FP&%!PXFV,9=P?8$!Q)0T!OGP#5LV;0EV'&',%P$W@Q@%W\=>_;Q MV[5O%]^]7;IQ!I?8+/\X;EVW=O/0O3-P\*->GR%)D!B);P0)D2*$VB$D%"0^ M_?A!.%./(D/41P1]]B%XH'Q)'/$?$@$*I$XN>Z"BAC@LU:/*`S.P,`,-*/3` MP@H@BDABB"R@<$('Q!14QP0B?HBBC":6.&(/*'2XP@P_T&/.CA[:^"$#+1XD MS@PKK(`CC4'.:..)->9X8XXT*.GA!*5(T@&34(X(HHY+3HF"%/6D\0`**&S9 M`9I;/M`,0E=PN&::,W3P`#/UU'$FG1UXD&::'M3)IJ`H6%#GG5/%><4A1-SP MS4JC1`!""2VP<,).E5Z*@@J6XL3I"1]T``Q!:GA`::>G:OJIIYUN"L((.]#_ M@PZFJ&8*@A#:&%F""B"REPWZ6!4)@F(HLI1-(H\T(JVX*K:>8;HKI!,;4D\LF862!1P8V$&+91?.X M\H`'+G10*;_^LL"ON0-S"C`'V`Q$AP9 MTP&P'4Q<*<@/8TPPJRB(S(($J]3A@<0F&PRQR!T046VS#DOL*BWWUM.MO^KZ M&RXU##Q\\M$D!]T"N_7D$8X73M2Q1#>LD'32-0^`P(),-&T]TPI;D]@A330@ M2=,$CB161\A=[?-MTQ5 MAETVX8O3_?4$KNQ10N%OBZVXWA[.Y($3]90QN==MGVA!.`:%P7;A$TQ#C0>A MEWTYX9D;'L,$Q]2SQS=D(%$")_6$8K5);&@FL&?7$L]9I:#YRH().(G`P@*F M"#2'!L1;2KP+OGZ&/?(X56J""C?0\_YQ`GB:QQHZ@(UY$&(!"3,)/0C!`'0-:P0Y M&(4YQ,&*(ZP19>AB@"OJ4:IAI0H(?\!#'?Z@AU3B@95_J`,>X(`(61'KEKMB M00:B01!Q[&HGENR7!'I3@=^XI@*]8E6Q1C`;">AF-@KP!"%>AJU,[>0'KVPE M'K)9!UFF,@V\"P,U;VDN%'B`!NL@2+=*8,FE7<,:&;"FN33E3`8T\YD/J&=O MBC3_CU"@PA29Z$8*)S(/"P"-9`*[%3<(H@Y:>$`%2',!!V(U"(:5K%(.0`1$ MQ)$QF)6,4QQX03<&XC'2(*L#'R`#,((1C)6NM*5.D,#,7"4%E[9TI;W`'A MKM:5A7H]R!H\@-:_TJ`#EDC(%CY7V!Y,8!(06>Q=^VJY'GB`".H82!@FY]>O MILX:$TA<86-P@_5EM2&NF-\"/9"&@:JA6?"3WTYZ\0CJ_YV/>!ZPPT;)%\#- MV`][%*@%^]PW,.==Z@&-2`@:/+#!_+%``QI%"!<`V*OKG8`"D'W(='N[O=%L M;P)@T&P$;TM!"V*0@:%I`59/^Q!::#%%+US!!"B1$&TH<8W[4J(*&,")2?00 MD/'U0!XVFB,8QG>/*WCA"9R0V7`@Z;TQ?``A$B('/W7QA4!\0"42LH8-<#$G M@_1`8!NB!K8B>)`7QF()`P7DZE;%,>B"M"Q#GF,I?@!U;& M_K3G<[L MC6617J59H`<#;0(%8SUI2HN8HJR_*OQ5<0QTH+35I MXIR0--39@PV<,$*R(%2C?<`"#IAUK1]P:PL4C1T"":I'G]X*$6W!T#`@%[U"%(?8NH`WH6+&$/;M@./!`ADMTWPOW-\4$.P6H9%Q&_.XZ" M,ZBC#B7_<'A=/QO:C5-V!G7K`0AV!(*N[F@"OGBW0SNHJ0\`X=X.F1[/K4MT MG;E/!KGF[0*KF\'1@"`-[HMMIY"K7.;BKU+034TG]!.##=CVV_ML- M>MT%#!"%'<9[+9Q4\((9;'IQ6W6M"N3\QNZ-+WS-202@-V0.#]`[%A,\>`SO MW8>Y'OS>D\2AG!@^P1S:^XMM(.%B6SB,@=0PASV\^,<;'HM`S,D-Q*X&SA=^ M4XX/9`S_C."]2R#&J8_OYV>?DQ1YX.[LG04+;D(3'>-$"'YGB,L6[?LRPP!L M:`8;[SUP@UP7/V4[%H(J_)K\,M-D!;S7"0P\(&>#T)EOR<]S_T+X#'U,@Y]O MV=_)#L1._N>#(!0_\!OZ<:+]K_F^TM88@?F[5OWTIS\#[C9JR)9>%N`#J<80 M"R,:`_,PKV9K$P!KLC8!$;`"SJ>`W0,",M`T%,`_R#:`'H!=Q<9VR.8!RG80 MS&9T'*ATO"51.6`UVK:``N,!RU`),U0]*WB#2R,-3&4T*9""U[."[:9S-#!O M5H(C-V`."3$/XB`.YM"$3F@.X>`.:T6$(M(#-'`K3^`%5Q`%8>`$5["%81`% M5Q`&`O520=2`0"^D`G.#(0?!#'X",+S" M+PV@BH%73N_XB@\A#IF&11[P`YEU#1QP1:%G`R$#7VP%7Y6'$&G`,$"D`@I) M9ARP80A1>G;VCOU2`2/&$`FTD>K2`$7B"P_%D)CFCBCP>G\$,N^HD#9P@.\V M$/-@$_;W9#/_('X&@0T[H7Q?,S<3$`J2(&FQ0V8CL`<;57PS\#4A(FJ_\`"' M,W_7%P/8%()Q#O``6$.4&8&1H@")$BR%LDF!`GB(HN\`"1`%2P94`5<)8" MT0U#4`$>R#V=06ZR59B5<@YVN1#TT&%18B(X<@)K<`G+<`AA,`%.4ISM00AH MPIL>P@(=0`CN\)SNH`[/V0[1.9WLP!SF8(8%1@-UZ0MG8HE-$B55_PF1C\B' M=WAQ!W&(>VB)S4F=TND.[CF=T7F=]9`%B-B&6:F:`E$+#U`E;8@B4+)4D9>( M5=(AP7>;]6`-DU(NY2(!%G`"%?`QN)0I'@`(];!VGL)TP((".7`#-J`#,]"A M'TH#'1JB2"`^Q=)SLTB3F>":N/BBH[F+!U%*(T,K62==&W`LZJ(\'QJB'JH# M)'H#,P"D+;`MTEB,&:`,!#$/DQ!!W-@JW@B.VZ,NE%(+*^4+-C555A4,O;!> M[$4`TC18T*G,I#>,!N0)XH!0T*M`G+*0",_2FG,%\XF-N..$!*TI2.6!. M/-6G#R"C!A&1`8-0&H"1!Q&294:FYB2G'O_`J"Q4`4A0#VR0HXD*+$12$-YP MD$,U,"SI)R`C,L;4`,5D3PV@3PV@`+5S8^*@.WI3-F49E5B)`D7B,G#SJHZ# ME;L'!+*R>R[@JC31E`41"A,`.I2S->,Y9Z=#K!.0"0G!E;$3E[!:K#(Q)O7` ME;X:ES)H$,3`$X;3./+UEM"*JVX#.GHS`?K)7K7``"950/'C@^05`4``C?60 M@/@SF_)3/]4S4;84F?F#@76Y5\1E@S^XF0=A;!WDF258.J?9KJJE=+_5&1W` M!#?#KO*3F@=A!>>57GJ9@_`TFYBY0,*67DPSDZ.P)V!"2#"T)%_R`#\@CWGB M)R<;LR62LD'4!!;_\R53,DC<:1"ND)R`))ZD.!!I\(@IFR,.!)HGD+,IHK(A M0K-0T@&<$P9)BT,OEJT&@0Y-8&(`^B4"*K--RR5/PK7M8I>J(`2FPJ"3\BVV M4@)X\&/26=RJ_^%R)H'64RFC! M,J%T%ZF(&BT94"0&P0H2<"XKJ3K@F+94NHWRU(VI:I?E8`4=("D%DS%*)0$V MH`NETQJT440BHS2:=Z2Q#TR&HR`[@0:5$L`#)PFE%?9A!E M\`#P*&ZDZS"ORVH?@$#&FY7(P@#6>!#SH`>L^S$Z$Z5*PZ?^LKQB2E0._\!+ M"$H/QC`)3="W%H`"/+%]ZFL!)4`(G?"O`U$+DQ`*EA`*DS`I!E4"[CM#_%L" M'M"_`)R-.B`KV6A0'="_$Q`#\CL0+S+`_QO`)?"0R$I79:4$7V`%G_`)O%`. M!N$%#]`!_[N_[BO!)2S`)OP`=W,&$B#"_2O"#P"Y!M$-,X"^$&QMU@`-#$#" M`&PJ)QS!%E!6:)*-7H"Z"$H0Z(`-RP`%#(($]#$,=_00VW`-VH`-5$S%5JP- MUX`-6JS%7'P-/S$/68P-7US%VC!0[V#%9;S%7NRR@@!EE@ M`_01!4(P#,\0"['@I4=<#XX1RG_YR3/)MS`I!FC0!&@R`610#9^`QP=`RN_F M#LF@"=S@&/4@#(N@"8O@P;+\RZ0!@ MSO!\6GHR!G[0`?LF7S_%#;P0SRKA#OC@S/P^@RMD,HP#>H#"VGOW5PXL._QP+`Z$.N-W9R8!5Z&#:Q%T/[UT/EOW5=0D. M>!S8]5`.,4W-\5T/L=`*B?P,O$S4`C$/]Y#'B3S?BZ#@]6#`I$-NZSA!,'?TTT0V8#''CS? MZ/W0Z9P8Y8#'U,Q0"XX.ZJ#:PST0)Y[C1@[5"G[;B\#B!!$+>;Q>!Y#;!?'A M(0[,SW#9#5'+B_#C`]'@G'WAN]S`L+T(G3T0,N[!M6S+!L',K<#CO'SF!%$. MPH#56\W5=3D/14X0"*X)"F[2Y@3>Y#WCYEHAUEQ-U2K]U('@Z+R0#7GMY/4`#E!= M#07QUN2LTGF]UP;!#;OLRUF.#Y;AZMN]Z+*#O^LZ`0.RP6!U<9^Y+QN$#6N";YL MZ):!ZS,.[)][9K>U/^LX2>^"/4]$%"NSO_]RK,.[7B,S?#^;M&NW#(9\?>"#AJO M[=AN$.CLS@5Q`*\SM6)#.B)'/,$0>'E7MW+O:3_ M;.P]KNXJ3N@??\3N`.7*S>S%'8",=@V;Q"`;AE3GL>)@=48_^1Q M+A!9'NB3OLO@[NN?4)?J[>@M;]9>RNY+ZO3=SLN"OM[EO/0LX>Y-7@[K[/;H M<-E?I@Y9O@@>??7I++^B;NOXW?6:`.LMCO:BI@YD+NOS@.EZ_VX'\-9XC`_5D/M8[\%, MWN0'4`W-G>U67MDQ_0R_;_OO7NK-'`NYW]4PWO0.SE!O_3@W5 M]/\)V=[CZ6P0RO[*`!%(X*)/PMS50YBPWKU/BP;B2Z807*!%L>8IK'<`WR*' M%<$="*0I$+YR]>8)XRCPTT5N'./@.XCP64J*FF+%1-@J4"R,]6)QK-A3Z%"B M18T>19I4J=!RV;@]A=JSZ=-LZC#.RY8-7,\##7E!S5:2Z%1NV7`B=)?U8D^L M4>NIX/AB3,MMZU+"A0T?1IPXZ<]/@Q4_AAQ9\F3* IE2GS"FI9\V;.G3U_QHB9)VC2I4V?/LWMDR9>J%V_AAU;]@3LQP$!`#L_ ` end